Inhibikase Therapeutics, Inc. [IKT] - Inhibikase Therapeutics appoints Scott Wasserman as director

Scott Wasserman was appointed as a Class III director and member of the Compensation Committee of Inhibikase Therapeutics, effective October 19, 2026, following the resignation of Dennis Berman from the board.

View source filing ↗